"Glaucoma is a group of diseases that damage the optic nerve, a cable at the back of each eye that connects it to the brain. It affects more than 2.7 million people in the United States and more than 60 million worldwide. There are many forms of t"...
- Patient Information:
Details with Side Effects
DOSAGE AND ADMINISTRATION
Betimol® (timolol ophthalmic solution) Ophthalmic Solution is available in concentrations of 0.25 and 0.5 percent. The usual starting dose is one drop of 0.25 percent Betimol® (timolol ophthalmic solution) in the affected eye(s) twice a day. If the clinical response is not adequate, the dosage may be changed to one drop of 0.5 percent solution in the affected eye(s) twice a day.
If the intraocular pressure is maintained at satisfactory levels, the dosage schedule may be changed to one drop once a day in the affected eye(s). Because of diurnal variations in intraocular pressure, satisfactory response to the once-a-day dose is best determined by measuring the intraocular pressure at different times during the day.
Since in some patients the pressure-lowering response to Betimol® (timolol ophthalmic solution) may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment with Betimol® (timolol ophthalmic solution) .
Dosages above one drop of 0.5 percent Betimol® (timolol ophthalmic solution) twice a day generally have not been shown to produce further reduction in intraocular pressure. If the patient's intraocular pressure is still not at a satisfactory level on this regimen, concomitant therapy with pilocarpine and other miotics, and/or ep-inephrine, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide can be instituted.
Betimol® (timolol ophthalmic solution) is a clear, colorless solution.
Betimol® (timolol ophthalmic solution) 0.25% is supplied in a white, opaque, plastic, ophthalmic dispenser bottle with a controlled drop tip as follows:
|NDC 68669-522-05||5.0mL||fill in||5 cc container|
|NDC 68669-522-10||10mL||fill in||11 cc container|
|NDC 68669-522-15||15mL||fill in||15 cc container|
Betimol® (timolol ophthalmic solution) 0.5% is supplied in a white, opaque, plastic, ophthalmic dispenser bottle with a controlled drop tip as follows:
|NDC 68669-525-05||5.0mL||fill in||5 cc container|
|NDC 68669-525-10||10mL||fill in||11 cc container|
|NDC 68669-525-15||15mL||fill in||15 cc container|
Store between 15-25°C (59-77°F). Do not freeze. Protect from light.
Marketed by: VISTAKON® Pharmaceuticals, LLC Jacksonville, FL 32256 USA. Manufactured By: Santen Oy, P.O. Box 33, FIN-33721 Tampere, Finland. November 2006 Version.
Last reviewed on RxList: 3/26/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Betimol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.